Fusion Pharma: AstraZeneca completes acquisition of clinical-stage cancer drug company

AstraZeneca completed the acquisition of Canada-based Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing radioconjugates (RCs). The acquisition is part of AstraZeneca's effort to improve cancer treatment and outcomes for [...]The post AstraZeneca completes acquisition of clinical-stage cancer drug company appeared first on Delaware Business Now.